Skip to content
Home/Companies/Biotech/TiGenix

TiGenix

Biotech·BE·Exited 2018·Held 11yr
Entry
2007
Hold
11yr
Exit
2018

Who owns TiGenix?

TiGenix was owned by Ysios Capital Partners through Ysios BioFund I (2008 vintage) from 2007 to 2018, exited via Trade Sale.

Buyer identity available on Pro.

Hand-verified · updated 2026-08-03

Ysios Capital Partners
Investor
Ysios Capital Partners
Ysios BioFund I · 2008 · Life Sciences VC

Key facts

HQBE
SectorBiotech
StatusAcquired
Exit Type
Trade Sale
Buyer
MOIC
–
Exit Year
2018

More from Ysios BioFund I

Other portfolio companies in the same fund.

Galecto Biotech
Exited 2020
BiotechDK· 2018
Sanifit
Exited 2021
BiotechES· 2015
to
KALA BIO
Kala BIO
Exited 2017
BiotechUS· 2014
AM Pharma
AM Pharma
Active
BiotechNL· 2011
MedLumics
Active
MedTechES· 2011
STAT-Diagnostica
Exited 2018
MedTechES· 2011
to

More PE-backed in Biotech

Comparable biotech deals from other GPs.

Antiverse
Antiverse
Active
Future Planet CapitalUK
CellCentric
CellCentric
Active
Future Planet CapitalUK
Crescendo Biologics
Crescendo Biologics
Active
Future Planet CapitalUK
Cytox Group
Exited 2024
Future Planet CapitalUK
GenSight Biologics
GenSight Biologics
Active
Sofinnova PartnersFrance
Healx
Healx
Active
Amadeus Capital PartnersUK
Track TiGenix

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Get the full record on TiGenix.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyer and MOIC on this deal (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue